Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics.
**TOP 10 LIFE SCIENCES PODCAST**
Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market?
Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development?
Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?
There’s a way to simplify and streamline so you can remove complexity, skip trials and errors, deliver without delay your groundbreaking therapy to clinics and market, and still enjoy every single step.
Hey, I’m David Brühlmann, biotech entrepreneur and consultant, international technology transfer expert, and innovation coach. I’ve been there. And guess what, science may give you headaches, but biologics drug development should not.
Want to learn how I and many industry experts did it?
- In this podcast, you will learn:
- How to develop bioprocesses with peace of mind
- How to master biologics drug development
- How to deliver your life-transforming therapy to clinics and market fast and efficiently
- How to actually enjoy doing all this
I can’t wait to help you do biotech the smart way.
Grab a cup of coffee and your favorite notebook and pen. Now is the time to take your bioprocessing game to the next level.
Ready? Binge-listen mode: Go!
Next Steps:
Visit the Website: www.smartbiotechscientist.com
Email us: hello@bruehlmann-consulting.com
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
81: Regenerating Muscles: The Future of Autologous Cell-based Therapy with Deana Mohr - Part 1
Discover how scientists are transforming lives through innovative muscle regeneration therapy. In this captivating episode, Deana Mohr, CEO and co-founder of MUVON Therapeutics, spin-off from the University of Zurich, unveils her groundbreaking autologous muscle regeneration technology for treating stress urinary incontinence.
Learn how this minimally invasive treatment harnesses the power of a patient's own cells to restore muscle function, offering hope to millions. Diana shares her journey from PhD research to clinical trials, revealing the challenges of translating cutting-edge science into real-world treatments.
Listeners will gain insights on:
- The potential of autologous muscle tissue regeneration and the hurdles of medical innovation.
- Navigating the complex path from lab to clinic
- Key differences between muscle-based and CAR-T cell therapies
Whether you're a scientist, investor, or simply curious about medical innovations, this episode offers a fascinating glimpse into the future of regenerative medicine. Tune in to explore the forefront of biotech entrepreneurship!
Connect with Deana Mohr:
LinkedIn: https://www.linkedin.com/in/deana-mohr-haralampieva-95a9a5a4
MUVON Therapeutics: https://www.muvon-therapeutics.com
Next Steps:
Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at hello@bruehlmann-consulting.com